Medtronic plc ($MDT) Earnings (Q4 FY22)
Medtronic plc ($MDT) Earnings and Opinion: Medtronic is a company in the Healthcare sector and operates in the Medical Devices industry. The company develops, manufactures, markets, and sells device-based medical therapies to consumers. Medtronic was founded in 1949 and is currently headquartered in Dublin, Ireland. The company was first traded on the stock market in 1977. Medtronic EPS and Revenue (Q4 FY22): EPS of $1.52 missing expectations of $1.56 Revenue of $8.09B missing expectations of $8.43B Medtronic EPS and Revenue (FY22): EPS of $5.45 missing expectations of $5.66 Revenue of $31.69B missing expectations of $32.01B Medtronic Business Highlights: FY22 revenue increased by 5% EPS for FY22 increased by 40% Quarterly dividend increased to $0.68 FY22 cash flow from operations of $7.3B FY22 free cash flow of $6.0B Opinion: Medtronic stock sunk during todays session after reporting earnings before the market opened this morning. The company missed on expectations in both the c...